Stereotactic Body Radiation Therapy (SBRT)
Treatment for Liver Cancer Due To Nash
Typical Dosage: 30-60 Gy in 3-5 fractions
Effectiveness
75%
Safety Score
50%
Clinical Trials
50
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 Gy in 3-5 fractions
Time to Effect
weeks to months
Treatment Duration
1-5 fractions, typically 1 week
Evidence Quality
MODERATENumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$6,000
Side Effect Mgmt:$2,000
Total Annual:$38,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$70,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$47,500
Comparison vs TACE
Cost Difference
+$10,000/year
More expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Stereotactic Body Radiation Therapy (SBRT) Outcomes
for Liver Cancer Due To Nash
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+80%
Common Side Effects
Fatigue
+30%
Nausea/vomiting
+15%
Pain
+10%
Radiation-induced liver disease (RILD)
+7%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov